Senseonics Holdings Inc (SENS) Short Interest Up 0.5% in October

Senseonics Holdings Inc (NYSEAMERICAN:SENS) was the target of a significant growth in short interest in the month of October. As of October 31st, there was short interest totalling 19,063,824 shares, a growth of 0.5% from the October 15th total of 18,967,851 shares. Approximately 21.2% of the shares of the company are sold short. Based on an average daily volume of 1,895,436 shares, the short-interest ratio is currently 10.1 days.

NYSEAMERICAN:SENS traded down $0.44 during mid-day trading on Friday, hitting $3.53. 3,325,000 shares of the company traded hands, compared to its average volume of 1,529,275. Senseonics has a one year low of $2.41 and a one year high of $5.29.

Senseonics (NYSEAMERICAN:SENS) last released its quarterly earnings data on Thursday, November 8th. The company reported ($0.14) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.15) by $0.01. The business had revenue of $5.16 million during the quarter, compared to the consensus estimate of $5.16 million. The business’s revenue was up 145.7% on a year-over-year basis. During the same period last year, the company earned ($0.13) EPS.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Gilder Gagnon Howe & Co. LLC bought a new position in shares of Senseonics in the second quarter worth about $74,936,000. BlackRock Inc. lifted its position in shares of Senseonics by 51.9% in the third quarter. BlackRock Inc. now owns 5,790,360 shares of the company’s stock worth $27,621,000 after buying an additional 1,979,353 shares in the last quarter. Massachusetts Financial Services Co. MA purchased a new stake in shares of Senseonics in the third quarter worth about $14,703,000. PointState Capital LP purchased a new stake in shares of Senseonics in the second quarter worth about $10,970,000. Finally, Janus Henderson Group PLC purchased a new stake in shares of Senseonics in the third quarter worth about $12,222,000. 30.66% of the stock is owned by hedge funds and other institutional investors.

Several analysts have issued reports on SENS shares. BTIG Research reissued a “buy” rating and set a $6.00 price target on shares of Senseonics in a report on Thursday, August 9th. Dougherty & Co started coverage on Senseonics in a report on Friday, August 24th. They set a “buy” rating and a $6.00 price target for the company. Six equities research analysts have rated the stock with a buy rating, The company has an average rating of “Buy” and an average price target of $6.00.

ILLEGAL ACTIVITY NOTICE: This news story was first posted by WKRB News and is the sole property of of WKRB News. If you are viewing this news story on another website, it was copied illegally and reposted in violation of US & international trademark and copyright law. The correct version of this news story can be accessed at

Senseonics Company Profile

Senseonics Holdings, Inc, a medical technology company, designs, develops, and commercializes continuous glucose monitoring (CGM) systems for people with diabetes primarily in Europe. Its products include Eversense and Eversense XL, which are implantable CGM systems that is designed to continually and accurately measure glucose levels in people with diabetes for a period of up to 90 and 180 days.

Featured Article: Tariff

Receive News & Ratings for Senseonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics and related companies with's FREE daily email newsletter.

Leave a Reply